Slip Op. 01-138
United States Court of International Trade
RHODIA, INC.,
Plaintiff,
v.
UNITED STATES,
Defendant Before: Pogue, Judge
Consol. Court No. 00-08-00407
and
JILIN PHARMACEUTICAL CO., LTD.;
SHANDONG XINHUA PHARMACEUTICAL
FACTORY, LTD.,
Defendant-Intervenors.
[ITA determination affirmed-in-part and remanded-in-part.]
Decided: November 30, 2001
Williams Mullen Clark & Dobbins (James R. Cannon, Jr., Julia
Bailey, Francisco Orellana, Jimmie V. Reyna) for Plaintiffs.
Robert D. McCallum, Jr., Assistant Attorney General, David M.
Cohen, Director, Ada E. Bosque, Attorney, Commercial Litigation
Branch, Civil Division, U.S. Department of Justice; Emily Lawson,
Attorney, Office of the Chief Counsel for Import Administration,
U.S. Department of Commerce, Of Counsel, for Defendant.
White & Case (William J. Clinton, Adams C. Lee, Robert G.
Gosselink, Albert Lo) for Defendant-Intervenor Jilin Pharmaceutical
Co., Ltd.
Garvey, Shubert & Barer (William E. Perry, John C. Kalitka) for
Defendant-Intervenor Shandong Xinhua Pharmaceutical Factory, Ltd.
Consol. Court No. 00-08-00407 Page 2
OPINION
Pogue, Judge: This case is before the court on motions for
judgment upon the agency record challenging certain aspects of the
International Trade Administration of the United States Department
of Commerce’s (“Commerce” or “Department”) Notice of Final
Determination: Sales at Less than Fair Value: Bulk Aspirin from
the People’s Republic of China, 65 Fed. Reg. 33,805 (Dep’t Commerce
May 25, 2000), as amended, 65 Fed. Reg. 39,598 (Dep’t Commerce June
27, 2000)(“Final Determination”) and the accompanying Issues and
Decision Memorandum, P.R. Doc. No. 155 (May 17, 2000)(“Decision
Memorandum”). This court has jurisdiction pursuant to 28 U.S.C. §
1581(c) and 19 U.S.C. § 1516a(2)(B)(iii).
Plaintiffs in these consolidated actions are foreign and
domestic producers of bulk aspirin. Foreign producers, Jilin
Pharmaceutical Co., Ltd. (“Jilin”) and Shandong Xinhua
Pharmaceutical Factory, Ltd. (“Shandong”), argue that (1) Commerce
erred in applying overhead costs at each upstream production stage
and (2) Commerce inappropriately applied a weighted average ratio
rather than a simple average ratio to calculate overhead, selling,
general and administrative expenses (“SG&A”), and profit rates.
Domestic producer, Rhodia, Inc. (“Rhodia”) argues that (1) Commerce
improperly used import data rather than domestic data as the
surrogate value for phenol; (2)Commerce erred in excluding
purchased salicylic acid from Shandong’s normal value calculation;
Consol. Court No. 00-08-00407 Page 3
and (3) Commerce incorrectly included sales of traded goods in the
denominator of the factory overhead ratio. The Department asks for
a voluntary remand for the limited purpose of removing sales of
traded goods from the denominator of the factory overhead ratio and
recalculating the ratio.
Background
On May 28, 1999, Rhodia filed a petition requesting the
imposition of antidumping duties on imports of bulk acetylsalicylic
acid, commonly referred to as aspirin, from the People’s Republic
of China (“PRC”). Rhodia alleged that the subject imports were
being sold at prices below fair market value. The Department, in
response, initiated an investigation, see Initiation of Antidumping
Duty Investigation: Bulk Aspirin from the People’s Republic of
China, 64 Fed. Reg. 33,463 (Dep’t Commerce June 23, 1999), and
preliminarily determined that bulk aspirin from the PRC was being,
or was likely to be, sold in the United States at less than fair
value (“LTFV”) as provided in section 733 of the Act. See Notice
of Preliminary Determination of Sales at Less Than Fair Value: Bulk
Aspirin from the People’s Republic of China, 65 Fed. Reg. 116
(Dep’t Commerce Jan. 3, 2000)(“Preliminary Determination”).
Pursuant to section 1677b(c), and in accordance with its
treatment of the PRC in all past antidumping investigations,
Consol. Court No. 00-08-00407 Page 4
Commerce found the PRC to be a nonmarket economy (“NME”) country.1
See Preliminary Determination at 117. Finding India to be at a
level of economic development comparable to the PRC and a
significant producer of bulk aspirin, Commerce selected India as
the surrogate market economy country in accordance with 19 U.S.C.
§ 1677b(c)(4). See id. at 119; see also 19 U.S.C. §
1677b(c)(1)(The normal value of goods in a NME country may be
ascertained by determining the cost of the “factors of production”
used to manufacture the goods.). No party challenges the use of
India as the surrogate market economy. See Letter to Sec. Daley
from the Law Firm of Stewart & Stewart, P.R. Doc. No. 75 at 1 (Oct.
8, 1999).
Standard of Review
The Court must uphold a final determination by Commerce in an
antidumping investigation unless it is “unsupported by substantial
evidence on the record, or otherwise not in accordance with law .”
19 U.S.C. § 1516a(b)(1)(B)(i).
1
The term “nonmarket economy country” is defined by statute
as “any foreign country that the administering authority
determines does not operate on market principles of cost or
pricing structures, so that sales of merchandise in such country
do not reflect the fair value of the merchandise.” 19 U.S.C. §
1677(18)(A).
Consol. Court No. 00-08-00407 Page 5
Discussion
Commerce calculates an antidumping duty margin by comparing
the imported products’ price in the United States to the normal
value of comparable merchandise. See 19 U.S.C. § 1677b(a).
Generally, normal value is the price of the merchandise in the
producer’s home market, its export price to countries other than
the United States, or a constructed value of the merchandise. See
19 U.S.C. § 1677b(a)(1). When the exporting country is a NME
country, however, section 1677b(c) requires that Commerce “shall
determine the normal value of the subject merchandise on the basis
of the value of the factors of production utilized in producing the
merchandise and to which shall be added an amount for general
expenses and profit plus the cost of containers, coverings, and
other expenses.” 19 U.S.C. § 1677b(c)(1)(B).
I. Application of Overhead Costs at each Upstream Production Stage
Once Commerce determined India to be the appropriate surrogate
country for the PRC, it sought surrogate values for each factor of
production, and for general expenses and profit. Factory overhead
is “one component of a product’s cost of manufacturing.” See Air
Prods. & Chems., Inc. v. United States , 22 CIT 433 , 441, 14 F.
Supp. 2d 737, 745 (1998). The value of factory overhead is
calculated as a percentage of manufacturing costs. See id.;
Magnesium Corp. of Am. v. United States, 20 CIT 1092, 1102, 938 F.
Supp. 885, 896 (1996). Commerce calculates a ratio of overhead to
Consol. Court No. 00-08-00407 Page 6
material, labor and energy inputs (“MLE”) for producers of
comparable merchandise in the surrogate country, India, and then
applies this ratio to the NME producer’s MLE. See 19 C.F.R. §
351.408(c)(4).
In its final determination Commerce used data from three
Indian producers of aspirin inputs to separately account for
overhead costs for each upstream production stage for Jilin and
Shandong. 2 Commerce determined that “the degree of integration of
a facility affects a facility’s overhead costs.” Def.’s Mem. Opp’n
to Mot. J. Agency R. at 22 (“Def.’s Mem.”). Because it determined
that none of the Indian producers reflect the degree of integration
represented by Shandong and Jilin, Commerce concluded that a single
application of an overhead ratio would understate overhead
expenses, not reflecting the expenses incurred to produce two major
inputs into aspirin and the final aspirin product itself. Decision
Memorandum at 11-12.
Jilin and Shandong argue, however, that not only did Commerce
merely assume that a fully integrated producer has a higher
overhead to raw material input ratio than a non-integrated
producer, but Commerce also assumed that the operations of the
Indian producers were not fully integrated. Shandong further
argues that Commerce’s methodology is a change from Commerce’s
prior practice and contrary to the plain language of the statute.
2
Commerce used surrogate values from three Indian producers:
Alta Laboratories, Ltd. (“Alta”), Andhra Sugars, Ltd. (“Andhra”),
and Gujarat Organics, Ltd. (“Gujarat”). See Shandong Br. at 24.
Consol. Court No. 00-08-00407 Page 7
A. Accordance with law
Section 1677b(c) requires normal value to be calculated “on
the basis of the value of the factors of production utilized . .
. to which shall be added an amount for general expenses and profit
plus the cost of containers, coverings, and other expenses.” 19
U.S.C. § 1677b(c)(emphasis supplied). Shandong argues that
Commerce, by applying an overhead ratio at each upstream production
stage, added amounts and costs into the dumping margin calculation.
Shandong Br. Supp. Mot. J. Agency R. at 13 (“Shandong Br.”).
Rather, according to Shandong, Commerce should have applied the
overhead amount at one time and as an overall percentage. In
support of this argument, Shandong cites to the Department’s
Antidumping Manual and what it argues is mandatory language in the
statute. See id. at 13-14; Int’l Trade Admin., U.S. Dep’t
Commerce, Antidumping Manual , Chap. 8 at 85(1998)(“ Antidumping
Manual”); 19 U.S.C. § 1677b(c).
The statute does require that the Department include an amount
for overhead expenses. Commerce, contrary to Shandong’s
assertions, did only include “an” amount. “Amount” is defined as
“a: the total number or quantity; b: the quantity at hand or under
consideration.” Merriam-Webster,available at http://www.m-w.com.
In this case, Commerce argues that to account for the overhead
expenses of an integrated producer, it was necessary to look at the
expenses incurred during each stage of the multi-stage production
process. Commerce used surrogate factory overhead values for each
stage of the multi-stage process and calculated a total amount
Consol. Court No. 00-08-00407 Page 8
based on these figures. The calculated overhead rate was not
contrary to the statute as only a single figure for general
expenses and profit was included in normal value. Normal value,
therefore, only included the total number and quantity under
consideration, consistent with “an amount,” not “amounts” as
Shandong contends.
Furthermore, Shandong’s reliance on the Antidumping Manual is
misplaced. 3 The manual, under a section entitled “Sample
Calculation for [Normal Value],” presents a “very simple example of
the type of factors valuation calculation that is done in
investigations or reviews involving merchandise from a NME
country.” Antidumping Manual, Chap. 8 at 92. The methodology that
the manual presents is merely an example; further, it is a “very
simple example.” This implies that Commerce is not bound exactly
to this very simple example in the Antidumping Manual rather, the
;
Manual presents a model that illustrates one approach to
calculating the factory overhead ratio. The production process
utilized in the making of bulk aspirin, however, is not a simple
process. Therefore, Commerce did not depart from prior practice by
not following the Antidumping Manual ’s “simple example”; but
3
It should be noted that while the Antidumping Manual “is
not a binding legal document, it does give insight into the
internal operating procedures of Commerce.” Koenig & Bauer-
Albert AG v. United States, 24 CIT , , 90 F. Supp. 2d 1284,
1292 n.13 (2000), aff’d in part, vacated in part, remanded by 259
F.3d 1341 (Fed. Cir. 2001).
Consol. Court No. 00-08-00407 Page 9
instead used this model and adapted it to a more complex situation.
B. Substantial Evidence
Shandong and Jilin also argue that the Department did not show
why overhead would be higher for an integrated producer, nor
support its finding that Indian producers have a lower overhead
with evidence from the record.
Commerce’s determination is reviewed on the basis of the
reasons articulated and evidence relied on in its decision. SEC v.
Chenery Corp., 332 U.S. 194, 196 (1947). Furthermore, Commerce
must articulate a “rational connection between the facts found and
the choice made.” Burlington Truck Lines, Inc. v. United States,
371 U.S. 156, 168 (1962).
In this case, Commerce adopted Rhodia’s argument, stating in
its Decision Memorandum that “[a] fully integrated producer will
have an overhead to raw material input ratio that is higher than
the same ratio for a non-integrated producer, other things being
equal.” Decision Memorandum at 11 (“[W]e agree with the petitioner
that degree of integration is a relevant factor that can affect
overhead rates.”). Beyond this conclusory statement, Commerce gave
no explanation for its finding that producers of bulk aspirin in
the PRC are more integrated than the surrogate producers in India.
See id. at 11-12. The Decision Memorandum also failed to identify
any evidence in the record to support Commerce’s conclusion. For
example, Commerce does not cite any evidence to support its finding
that vertically integrated producers have higher overhead costs or
Consol. Court No. 00-08-00407 Page 10
that, except with regard to the level of integration, the Indian
and PRC producers are otherwise “equal.” Although Commerce’s brief
addresses in greater detail the reasons that integrated producers
have higher overhead costs, the “‘post hoc rationalizations’ of
counsel [cannot] supplement or supplant the rationale or reasoning
of the agency.” Hoogovens Staal BV v. United States, 24 CIT __,
__, 86 F. Supp. 2d 1317, 1331 (2000)(internal citations and
quotations omitted); see also Burlington Truck Lines, 371 U.S. at
168-69; Fed. Power Comm’n v. Texaco, Inc., 417 U.S. 380, 397
(1974).
Not only, however, did the Decision Memorandum state that
integrated producers have higher overhead costs than non-integrated
producers generally, Commerce also found that producers of bulk
aspirin in the PRC were more fully integrated than the Indian
surrogates. See Decision Memorandum at 11 (“After considering all
available information on the record, [Commerce] determine[d] that
none of the Indian producers reflect the degree of integration
represented by the respondents in this investigation.”). Of the
three surrogate companies only one, Andhra, produces aspirin, and
its aspirin production is equal to just 3.57 percent of the
company’s total sales. See id. The other surrogate Indian
companies, Alta and Gujarat, do not produce aspirin but do produce
salicylic acid and derivatives. See id. Based on this evidence,
Commerce determined that the Indian surrogates only produce aspirin
inputs and, therefore, “are more representative of the overhead
expense incurred by the upstream input producers.” Id. at 12.
Consol. Court No. 00-08-00407 Page 11
Commerce’s determination that the Indian surrogate companies
only produce aspirin inputs is flawed. This statement is based on
the premise that (1) Andhra produces only a minuscule amount of
aspirin, so the majority of its output is also aspirin inputs; 4 and
(2) Alta and Gujarat produce salicylic acid and derivatives and
that these derivatives are aspirin inputs. While salicylic acid is
an input in aspirin production, aspirin is also a derivative of
salicylic acid. See Jilin Mem. Supp. Mot. J. Agency R. at 18
(“Jilin Br.”). Salicylic acid derivatives, therefore, are not
necessarily just aspirin inputs. Alta and Gujarat, as producers
of “salicylic acid and derivatives,” and Andhra as a producer of
bulk chemicals other than aspirin, could be producers of
merchandise identical or comparable to aspirin. Therefore, the
conclusion that Indian surrogates only produce aspirin inputs does
not follow from the premise that Alta and Gujarat produce salicylic
acid derivatives and Andhra produces bulk chemicals. Consequently,
Commerce’s conclusion is not based on a reasonable inference drawn
from the evidence in the record.
As previously discussed, Commerce’s findings must be “reached
by ’reasoned decision-making,’ including . . . a reasoned
4
The majority of Andhra’s production is bulk chemicals other
than aspirin. These chemicals include acetic acid, acetic
anhydride and caustic soda. See Decision Memorandum at 11-12.
According to Commerce, many of these chemicals are inputs for
aspirin production. See id. Absent some explanation from
Commerce, the Court cannot determine whether this evidence is
sufficient to support Commerce’s conclusion that Andhra’s
overhead costs are not representative because the chemicals
produced are the result of a less integrated production process.
Consol. Court No. 00-08-00407 Page 12
explanation supported by a stated connection between the facts
found and the choice made.” Elec. Consumers Res. Council v. Fed.
Energy Regulatory Comm’n, 747 F.2d 1511, 1513 (D.C. Cir.
1984)(citing Burlington Truck Lines, 371 U.S. at 168). Here,
Commerce has not drawn a reasonable inference from the evidence in
the record in order to support its finding that producers in the
PRC are more fully integrated than the Indian producers or that the
salicylic acid derivatives produced by Alta and Gujarat or the
chemicals produced by Andhra are the result of a less integrated
production process.
By failing to make any findings regarding its choice, see
Taiwan Semiconductor Indus. Ass’n v. United States, 23 CIT __, __,
59 F. Supp. 2d 1324, 1336 (1999), aff’d, 266 F.3d 1339 (Fed. Cir.
2001), Commerce errs. Accordingly, Commerce’s overhead calculation
is remanded for reconsideration. On remand, Commerce is to
articulate the facts in the record that support its remand
determination.
II. Weighted Average v. Simple Average
In the final determination, Commerce calculated surrogate
overhead, SG&A, and profit ratios using a weighted average of the
three Indian producers; Alta, Andhra, and Gujarat.5 Jilin and
5
Commerce’s treatment of the overhead ratio provides an
example of the weighted average calculation. Commerce calculated
overhead ratios “by dividing the total overhead expenses for all
Consol. Court No. 00-08-00407 Page 13
Shandong argue that a weighted average is not appropriate when
there are a limited number of data points, that Commerce has a
long-standing practice of using simple averages, and that the
decision to use a weighted average is not supported by substantial
evidence.6 See Jilin Br. at 7, 22; Shandong Br. at 12.
In almost every antidumping investigation where Commerce uses
only a few surrogate companies, Commerce applies a simple average
to derive overhead, SG&A, and profit.7 See, e.g., Certain
three producers by the total expenses for materials, labor, and
energy. A simple average overhead ratio would first calculate
the overhead ratios for each of the three producers, and then
take the straight average of those three ratios.” Jilin Br. at 22
n.72.
6
Rhodia argues that Shandong and Jilin did not previously
raise this issue and therefore waived their right to have this
Court review it. Exhaustion, however, is only required to the
extent that the court determines it appropriate. 26 U.S.C. §
2637(d). Here, Shandong and Jilin were under no notice that
Commerce would apply a weighted average. It was not until the
Factors Valuation Memorandum on May 17, 2000 that the decision to
use a weighted average was made. See Memorandum, Factors of
Production Valuation for the Final Determination, P.R. Doc. No.
156 at 1 (May 17, 2000)(“Final Factors Memo.”). This was the
same day the Decision Memorandum was issued. See Decision
Memorandum at 1. Accordingly, neither Shandong nor Jilin will be
required by the court to further exhaust its administrative
remedies with regard to this issue.
7
In some cases, Commerce relies upon weighted average
information derived from the Reserve Bank of India Bulletin.
This information, however, is based on the aggregated financial
statistics of an entire industry sector. Here, Commerce only
used financial data from three companies. When only a small set
of numbers are used to calculate a weighted average overhead
ratio, the result will be significantly affected by the size of
the companies. In this case Commerce’s weighted average was
21.06. See Final Factors Memo. at 12. This is close to the
overhead ratio of Andhra, the largest of the three Indian
Consol. Court No. 00-08-00407 Page 14
Preserved Mushrooms From the People’s Republic of China, 65 Fed.
Reg. 66,703, 66,707 (Dep’t Commerce Nov. 7, 2000); Certain Cut-to-
Length Carbon Steel Plate from the People’s Republic of China, 62
Fed. Reg. 61,964, 61,970 (Dep’t Commerce Nov. 20, 1997). In only
one case did Commerce explicitly use a weighted average, and the
decision was not, in that case, questioned by the parties. See
Final Results: Tapered Roller Bearings and Parts Thereof, Finished
and Unfinished from the People’s Republic of China, 64 Fed. Reg.
61,837 (Dep’t Commerce Nov. 15, 1999). The issue of averages is
specifically addressed in very few cases, the most informative
being Notice of Final Determination of Sales at Less Than Fair
Value: Bicycles From the People’s Republic of China, 61 Fed. Reg.
19,026, 19,039 (Dep’t Commerce Apr. 30, 1996)(“Bicycles”).
In Bicycles, the respondents asked Commerce to calculate a
weighted average factory overhead, SG&A, and profit for each Indian
producer of bicycles because, the respondent argued, a clear
correlation existed between costs and production quantities for all
of the Indian bicycle producers. The Department rejected this
position, agreeing with the petitioners that the use of the
weighted average method would imply that the experience of larger
Indian producers was more representative of Chinese producers than
smaller Indian producers. According to the Department not all
producers. See id. To calculate Andhra’s overhead ratio of
21.64, we divided Andhra’s overhead cost of 372,987,500 by its
MLE of 172,353,400. See id. at Exhibit EE.
Consol. Court No. 00-08-00407 Page 15
Chinese producers were large scale producers. Moreover, several
factors, other than costs and production quantities, could affect
overhead, SG&A, and profit ratios. Consequently, Commerce “used a
simple average . . . consistent with [its] normal practice because,
barring evidence to the contrary, we assume that all of these
surrogate values are equally representative of the surrogate
experience.” Id. (emphasis added).
Here, no such findings concerning representativeness were
made. Commerce applied a weighted average with no explanation of
its reasoning. The general practice of Commerce is to apply a
simple average. In order to depart from this practice Commerce
needs to “explain the reasons for its departure.” Hussey Copper,
Ltd. v. United States, 17 CIT 993, 997, 834 F. Supp. 413, 418
(1993)(internal quotations and citations omitted); Allegheny Ludlum
Corp. v. United States, 24 CIT , , 112 F. Supp. 2d 1141, 1147
(2000). It is possible, on remand, that Commerce will determine
that a weighted average is the correct method to calculate the
necessary ratios. Commerce must, however, give an explanation for
this decision. See, e.g., Bicycles, 61 Fed. Reg. at 19,039
(indicating the necessity of citing evidence as to why the
surrogate values are or are not “equally representative of the
surrogate experience”).
Consol. Court No. 00-08-00407 Page 16
III. Import Data v. Domestic Data
Not only must Commerce assign surrogate values for general
expenses, but Commerce must also assign surrogate values to each
factor of production in order to construct a normal value.8 One
such factor of production is phenol, an aspirin input. See
Preliminary Determination at 119; see also 19 U.S.C. § 1677b(c)(3).
In order to calculate normal value Commerce assigned a value to
phenol using surrogate Indian prices.
India imposes a tariff on phenol imports that can be waived
through a duty drawback system. According to Commerce, this
creates a “two-tiered” price structure, one for use in the sale of
domestic products and the other for use in the sale of merchandise
for export. As a result of India’s tariff structure, Commerce
determined that the Indian domestic phenol price was artificially
high and, therefore, valued phenol by using the import price from
the India Chemical Weekly. Rhodia contends that Commerce not only
departed from prior practice by using the import price rather than
the domestic price but that this decision was also not supported by
substantial evidence. See Mem. Supp. Rhodia’s Mot. J. Agency R. at
2 (“Rhodia’s Br.”).
8
Factors of production include, but are not limited to,
labor, raw materials, utilities and capital costs. See 19 U.S.C.
§ 1677b(c)(3).
Consol. Court No. 00-08-00407 Page 17
A. Departure from Prior Practice
“[T]he valuation of the factors of production shall be based
on the best available information regarding the values of such
factors in a market economy country or countries considered to be
appropriate by the administering authority.” 19 U.S.C. §
1677b(c)(1) . As the statute does not define “best available
information,” it “grants to Commerce broad discretion to determine
the ‘best available information’ in a reasonable manner on a case-
by-case basis.” Timken Co. v. United States, slip op. 01-96, at 12
(CIT Aug. 9, 2001). This discretion is curtailed by the purpose of
the statute, i.e., to construct the product’s normal value as it
would have been if the NME country were a market economy country.
See Nation Ford Chem. Co. v. United States, 166 F.3d 1373, 1375
(Fed. Cir. 1999); Baoding Yude Chem. Indus. Co., Ltd. v. United
States, slip op. 01-117, at 4 (CIT Sept. 26, 2001); see also Air
Prods. & Chems., 22 CIT at 435, 14 F. Supp. 2d at 741 (citing
Tianjin Mach. Import & Export Corp. v. United States, 16 CIT 931,
940, 806 F. Supp. 1008, 1018 (1992); Timken Co. v. United States,
16 CIT 142, 144, 788 F. Supp. 1216, 1218 (1992)9).
In previous administrative reviews of a Chinese product
containing phenol, Commerce used the Indian domestic value of
9
These cases, regarding Commerce’s NME methodology, were
decided under the pre-Uruguay Round version of the antidumping
statute. However, this aspect of the statute was not changed by
the Uruguay Round amendments. Compare 19 U.S.C. § 1677b(c)(1988)
with 19 U.S.C. § 1677b(c)(1994).
Consol. Court No. 00-08-00407 Page 18
phenol in calculating normal value. Specifically, Rhodia points to
Commerce’s actions in Sebacic Acid from the People’s Republic of
China, 64 Fed. Reg. 69,503 (Dec. 13, 1999) and the preliminary
determination in the subsequent annual review of Sebacic Acid, 65
Fed. Reg. 18,968, 18,971 (April 10, 2000), where Commerce used the
India Chemical Weekly average domestic price. The valuation of
phenol in those administrative reviews does not, however, require
Commerce to use the domestic phenol price in the present case. The
decision on which price to use - domestic or import - is based on
which value will result in a more accurate normal value. In the
past, the domestic phenol value may have been “best available
information.” Previous circumstances and the mere fact that the
domestic price is available do not require Commerce to continue
using the domestic value of phenol. See Issues and Decision
Memorandum for the Administrative Review of Manganese Metal from
the People’s Republic of China, 66 Fed. Reg. 15,076 (Dep’t Commerce
March 15, 2001)(“[A] surrogate value which is the best available
information during one investigation or review does not necessarily
remain the best available information during subsequent reviews.”).
In fact, in the final determination for Sebacic Acid Commerce did
not value phenol using domestic India Chemical Weekly data and
instead valued phenol using India Chemical Weekly import data. See
Sebacic Acid from the People’s Republic of China, 65 Fed. Reg.
49,537 (Dep’t Commerce Aug. 14, 2000).
Consol. Court No. 00-08-00407 Page 19
Rhodia notes that Commerce has a stated preference for the use
of the domestic price over the import price, all else being equal.
This preference, as previously discussed, does not require Commerce
to use the domestic price in all circumstances. The use of the
domestic price as surrogate values is not appropriate when the
available domestic data is distorted by a protective tariff. See
Nation Ford, 166 F.3d at 1377; Baoding Yude, slip op. 01-117 at
14;10 Decision Memorandum at 5-6. In such situations the domestic
and import price are not “equal” surrogates. This practice is
consistent with Congress’ intention that Commerce not use distorted
surrogate prices. See Nation Ford, 166 F.3d at 1377-78; H.R. Conf.
Rep. No. 100-576, at 590 (1988), reprinted in 1988 U.S.C.C.A.N.
1547, 1623. Furthermore, in the past, Commerce has used import
prices to value factors of production where it determines that the
import price is the more accurate value. See Nation Ford Chem. Co.
v. United States, 21 CIT 1371, 1373, 985 F. Supp. 133, 135 (1997),
aff’d, 166 F.3d 1373 (Fed. Cir. 1999); Nation Ford Chem. Co. v.
United States, 21 CIT 1378, 1378-79, 985 F. Supp. 138, 139-40
(1997); Tehnoimportexport, UCF Am. Inc. v. United States, 16 CIT
10
This Court’s opinion in Baoding Yude is consistent with
Commerce’s decision here. In Baoding Yude, the previous
distortion of the domestic price was substantially diminished by
the reduction in the tariff. See Baoding Yude, slip op. 01-117,
at 14-17. Therefore, the import price was no longer the best
available information, as it had been in previous administrative
reviews; rather, the use of the domestic price resulted in the
most accurate normal value.
Consol. Court No. 00-08-00407 Page 20
13, 15-16, 783 F. Supp. 1401, 1404-05 (1992).
Therefore, in accordance with the statute, Commerce has the
discretion to determine that the import price of phenol is the more
accurate surrogate value for determining normal value in the PRC
under the circumstances present during the period of investigation.
Thus, Commerce’s use of import values is not a departure from its
prior practice and is appropriate as long as its decision is
supported by substantial evidence.
B. Substantial Evidence
According to Rhodia, the Indian tariff cited by Commerce does
not distort the domestic price but distorts the import price.
Rhodia Br. at 14, 19. Rhodia argues that Commerce ignored the
evidence, including the safeguard measures imposed by India on
phenol imports, demonstrating the tariff’s effect on the import
price. Id. at 18. Rhodia also contends that the record
establishes that the Indian surrogate producers purchase the
majority of their raw materials domestically and therefore Commerce
should have used the domestic price for phenol. Id. at 18-19.
Lastly, Rhodia argues that Commerce’s normal value determination
was internally inconsistent. Id. at 19.
There is substantial evidence supporting Commerce’s use of the
import price to value phenol rather than the domestic price.
Substantial evidence is “such relevant evidence as a reasonable
Consol. Court No. 00-08-00407 Page 21
mind might accept as adequate to support a conclusion.” Consol.
Edison Co v. NLRB, 305 U.S. 197, 229 (1938). “[T]he possibility of
drawing two inconsistent conclusions from the evidence does not
prevent an administrative agency’s finding from being supported by
substantial evidence.” Consolo v. Fed. Mar. Comm’n, 383 U.S. 607,
620 (1966).
Here, Commerce’s main reason for using the import value of
phenol was the existence of the 59.97 percent tariff imposed on
imports. See Decision Memorandum at 6. This import tariff,
according to Commerce, resulted in the distortion of the Indian
domestic price. In support of its decision, Commerce demonstrated
that by adjusting “the weight-averaged import phenol price (from
ICW) of 29.81 Rs/kg by the tariff percentage, the resulting value,
46.51 Rs/kg, is virtually equal to the weight-averaged domestic
phenol price from ICW - 46.50 Rs/kg.” Id.11 Commerce reasoned that
the high tariff, in this case, is being used to protect domestic
phenol. While it may be, as Rhodia claims, that the evidence in
the record could be construed to reach a different result, this
11
If the import price adjusted by the tariff is either equal
to or greater than the domestic price, as is the case here, it
supports Commerce’s finding that the domestic price is
“distorted,” in that it is protected by the tariff. The import
price is therefore a lower price and the tariff is added to make
the imported product more expensive in comparison to the domestic
product. The reverse is also true. If the adjusted import price
is less than the domestic price, it supports a finding that the
domestic price is no longer protected by the tariff. See, e.g.,
Baoding Yude, slip op. 01-117, at 14.
Consol. Court No. 00-08-00407 Page 22
court cannot conclude that Commerce’s inference is unreasonable.
See Am. Silicon Techs. v. United States, 23 CIT __, __, 63 F. Supp.
2d 1324, 1331 (1999), aff’d, 261 F.3d 1371 (Fed. Cir. 2001)(“The
specific determination we make is whether the evidence and
reasonable inferences from the record support” Commerce’s
findings.)(quoting Daewoo Elecs. v. United States, 6 F.3d 1511,
1520 (Fed. Cir. 1993)).
Commerce need not use the domestic value of phenol, as Rhodia
suggests, merely because the surrogate Indian producers use
primarily domestic raw material inputs. See Nation Ford, 166 F.3d
at 1377. In calculating normal value in a NME country, Commerce
must determine what the market price for inputs would be in the PRC
“if such prices . . . were determined by market forces.” Nation
Ford, 21 CIT at 1373, 985 F. Supp. at 135 (internal citations and
quotations omitted). Best available information is not a distorted
domestic price, even if the producers in the surrogate country use
the domestic product. Rather, best available information is the
price that results in the most accurate calculation of what the
cost of production would be in the PRC if the PRC were a market-
economy country.
Moreover, Commerce did not, as Rhodia appears to argue, ignore
the effects of India’s safeguard duties on the Indian import price
of phenol. In the Decision Memorandum, Commerce addresses Rhodia’s
concerns about India’s invocation of the WTO’s Safeguards Clause on
Consol. Court No. 00-08-00407 Page 23
phenol imports. See Decision Memorandum at 6. Commerce noted that
although the safeguard action did impose a duty on all imports of
phenol, this duty was not applied until after the period of
investigation. See id.; see also Rhodia Br. at 18. India did not
even invoke the WTO Safeguards Clause until August 12, 1999, more
than four months after the end of the period of investigation. See
Preliminary Determination at 117; Final Determination at 33,805.
Furthermore, a safeguards action does not indicate that the
price of phenol imports was distorted. Safeguard actions do not
account for whether imports are being dumped or are fairly traded.
See WTO Agreement on Safeguards at Art. 2.1. The only evidence
needed to impose a safeguard duty is injury to the domestic market.
See id. The safeguards action, therefore, does not demonstrate
that phenol imports were not fairly traded.12
Moreover, Commerce’s determination was also internally
consistent.13 Rhodia refers to Lasko Metal Prods., Inc. v. United
States, 16 CIT 1079, 1081, 810 F. Supp. 314, 317 (1992), aff’d, 43
12
As further evidence that the domestic values were distorted
by tariffs, Jilin notes that the domestic values “increased
substantially after the imposition of the safeguard duties.”
Jilin Br. Opp’n Rhodia’s Mot. J. Agency R. at 15.
13
Rhodia also states that Commerce used an “extreme
comparison,” comparing “the highest domestic value from any
source with the lowest import value.” Rhodia Br. at 15 (emphasis
omitted). Commerce, however, compared the average India Chemical
Weekly import value with average India Chemical Weekly domestic
value to determine the effect of the tariff. The comparison of
two average values is a reasonable comparison, especially when
the two values are obtained from the same source.
Consol. Court No. 00-08-00407 Page 24
F.3d 1442 (Fed. Cir. 1994), in support of its argument that use of
the import price for phenol’s surrogate value does not promote
accuracy in the dumping margin. In Lasko, the parties challenged
Commerce’s “mix and match” methodology.14 Id. at 1080, 810 F. Supp.
at 317. In that case, this court held that a mix and match
methodology is permissible under the statute, and “[o]nly if the
combination of surrogate values . . . would somehow produce less
accurate results would Commerce’s use of this information be
unreasonable.” Lasko, 16 CIT at 1081, 810 F. Supp. at 317.
Here, Commerce found that the best available information for
determining normal value is the Indian import price for phenol.
Commerce determined that the use of the import price, even though
it resulted in a mix and match methodology, produced a more
accurate result than using domestic prices to value all the
surrogate costs. This court has recognized Commerce’s use of both
import and domestic prices in order to obtain a more accurate
normal value. See Nation Ford, 166 F.3d at 1378 (Section “1677b(c)
merely requires the use of the ‘best available information’ with
respect to the valuation of a given factor of production; it does
not require that a uniform methodology be used in the valuation of
14
This “mix and match” methodology refers to a combination of
values used to calculate normal value. Lasko involved the
combination of surrogate values and prices paid by NME producers
to market-economy suppliers. Lasko, 16 CIT at 1080-81, 810 F.
Supp. at 316. The arguments in Lasko are equally compelling in
the instant case, where Commerce used different surrogate sources
within a single surrogate country to determine the most accurate
normal value.
Consol. Court No. 00-08-00407 Page 25
all relevant factors.”).
Moreover, the “purpose of the [NME] factors of production
methodology . . . is not to construct the cost of manufacturing the
subject merchandise in India per se but to use data from one or
more surrogate countries to construct what the cost of production
would have been in China were China a market economy.” Baoding
Yude, slip op. 01-117, at 22 (internal citations and quotations
omitted). As a result, Indian producers’ costs are not necessarily
the appropriate surrogates for all costs. Here, the domestic price
of phenol was a distorted price because, as Commerce explained, the
high tariff on imports influenced domestic prices. Consistent with
Congress’ directive to avoid such distortions, Commerce rejected
what it found to be an inaccurate domestic price, instead using a
“mix and match methodology” that allowed it to obtain the most
accurate normal value. “This type of line-drawing exercise is
precisely the type of discretion left within the agency’s domain.”
Baoding Yude, slip op. 01-117, at 17-18. As long as Commerce’s
methodology “seek[s] to effectuate the statutory purpose –
calculating accurate dumping margins,” as is the case here, and is
supported by substantial evidence, the margin will be upheld.
Shakeproof Assembly Components v. United States, 23 CIT __, __, 59
F. Supp. 2d 1354, 1358 (1999).
Here, Commerce “explain[ed] its finding of significance, with
sufficient . . . reference to the record[,]” and it is not the role
Consol. Court No. 00-08-00407 Page 26
of this Court to re-weigh that evidence. Shakeproof Assembly
Components v. United States, 24 CIT __, __, 102 F. Supp. 2d 486,
495 (2000), aff’d, slip op. 00-1521 (Fed. Cir. Oct. 12, 2001).
Therefore, determining that the import value for phenol was the
best available information on the record was a proper exercise of
Commerce’s discretion.
IV. Calculation of Normal Value for Shandong
Salicylic acid is a major input in bulk aspirin. Shandong
both purchases and produces salicylic acid. According to Shandong,
whether it purchases or produces salicylic acid determines the
quality of the end product. Based in part on this information,
Commerce concluded that only self-produced salicylic acid was used
in the production of the subject merchandise. As a result,
Commerce excluded costs associated with Shandong’s purchase of
salicylic acid, only including costs associated with Shandong’s
self-production of salicylic acid in calculating Shandong’s normal
value.
Rhodia, however, argues that the record does “not support the
conclusion that domestic-quality aspirin was in all cases inferior
or even different” from export-quality aspirin. Rhodia Br. at 23.
According to Rhodia, Commerce “assume[d]” domestic-quality and
export-quality aspirin were different “solely on the basis of
whether the aspirin has a certificate of compliance with the USP
Consol. Court No. 00-08-00407 Page 27
standard.” Id. Commerce, in Rhodia’s view, erred by not
considering whether purchased salicylic acid was used in aspirin
essentially equivalent to USP23-grade aspirin.15
A. Subject Merchandise
The antidumping statute defines the subject merchandise as
part of “the class or kind of merchandise that is within the scope
of an [antidumping] investigation.” 19 U.S.C. § 1677(25). The
only type of aspirin that can be sold in the United States is that
meeting USP standards. See Preliminary Determination at 117;
Petition from Law Firm of Stewart & Stewart to Sec. Commerce, C.R.
Doc. No. 1 at 40 (May 5, 1999). As a result, in the investigation,
Commerce defined the subject merchandise as bulk aspirin meeting
USP23 standards.16
15
Rhodia contends that Commerce did not establish that CP95
certified aspirin, the Chinese aspirin standard, is inferior to
USP23 aspirin, the United States aspirin standard. This argument
was not previously made before the agency because, according to
Rhodia, the issue was not raised until verification. Therefore,
Rhodia asks the court to take judicial notice of the published
standards, USP23 and CP95. It is not necessary for the Court to
consider Rhodia’s request as Commerce’s determination on the
scope of the investigation is affirmed.
16
The scope of the investigation was determined to be:
bulk acetylsalicylic acid, commonly referred to as bulk
aspirin, whether or not in pharmaceutical or compound
form, not put up in dosage form (tablet, capsule, powders
or similar form for direct human consumption). Bulk
aspirin may be imported in two forms, as pure ortho-
acetylsalicylic acid or as mixed ortho-acetylsalicylic
acid. Pure ortho-acetylsalicylic acid can be either in
crystal form or granulated into a fine powder
Consol. Court No. 00-08-00407 Page 28
Preceding the Initiation Notice, Commerce set aside a period
for parties to comment upon product coverage. Rhodia did not
attempt to do so. Even more compelling is that Rhodia, as the
petitioner in the underlying investigation, specified USP standards
as a description of the subject merchandise. See Initiation Notice
at 33,463-64. Rhodia argues that the issue of the scope of the
subject merchandise was not raised until verification. However,
Rhodia, as a party to the investigation, helps Commerce to “guide
the [investigation] process and must alert the agency to matters
which [it] believe[s] require unusually detailed inquiry.” Allied
Tube & Conduit Corp. v. United States, 25 CIT __, __, 132 F. Supp.
2d 1087, 1092 (2001); see generally Wheatland Tube Co. v. United
States, 21 CIT 808, 973 F. Supp. 149 (1997), aff’d, 161 F.3d 1365
(1998).
Commerce, in its Final Determination, found “that bulk aspirin
produced [by Shandong] for the Chinese domestic market (i.e.
domestic-quality aspirin) [was] distinct, in quality and
composition, from subject merchandise.” Decision Memorandum at 20.
The subject merchandise is USP quality aspirin, not just aspirin
exported to the United States, as Rhodia claims. The Department
(pharmaceutical form). This product has the chemical
formula C9H8O4. It is defined by the official monograph
of the United States Pharmacopoeia (“USP”) 23. It is
classified under the Harmonized Tariff Schedule of the
United States (“HTSUS”) subheading 2918.22.1000.
Preliminary Determination at 117.
Consol. Court No. 00-08-00407 Page 29
specifically found that the Chinese domestic-quality aspirin
produced by Shandong was of a different quality than that meeting
USP standards. See id. (“Shandong’s domestic-quality aspirin is
not within the scope of this investigation because it does not meet
the quality standards, as established by the United States
Pharmacopoeia.”). As a result, Commerce properly determined that
Shandong’s domestic-quality aspirin was not within the scope of the
investigation because it did not meet the USP quality standards.17
The statute requires Commerce to calculate normal value “on
the basis of the value of the factors of production utilized in
producing the merchandise.” 19 U.S.C. § 1677b(c)(1). During the
course of Commerce’s verification of Shandong’s facilities,
Commerce “reviewed invoices, certificates of analysis and
production/batch reports for both domestic and export sales of
subject merchandise.” Def.’s Br. at 50; see also Memorandum,
Results of Sales Verification of Shandong Xinhua Pharmaceutical
Factory, P.R. Doc. No. 140 at 12 (April 4, 2000); Shandong
Verification Ex. at F-4. Commerce verified that Shandong only uses
self-produced salicylic acid in the manufacture of export-quality
17
Additional evidence exists in the record demonstrating
that the USP23 standard has sixteen inspection items while CP95
has only eight. See Shandong Br. Opp’n Rhodia’s Mot. J. Agency
R. at 32 (citing to Shandong Verification Ex. at S-4); see also
Shandong Verification Ex. at F-8. Based on this, Commerce could
reasonably conclude that USP23 is a more difficult standard to
meet.
Consol. Court No. 00-08-00407 Page 30
18
salicylic acid. See Decision Memorandum at 20. In accordance with
the statute, Commerce only includes those factors of production,
such as Shandong’s self-produced salicylic acid, actually used in
producing the subject merchandise, USP quality aspirin. See id. at
20-21. Therefore, Commerce correctly determined and applied the
scope of the subject merchandise.
B. Low Cost
Rhodia argues that Commerce is allowing Shandong to manipulate
normal value through “cost-shifting.” E.I. DuPont de Nemours & Co.
v. United States, 4 F. Supp. 2d 1248, 1253 (1998). Allegedly, in
order to manipulate the normal value in this manner, Shandong would
assign low cost inputs, i.e. phenol, to U.S. exports and high-cost
inputs, i.e. salicylic acid, to domestic sales.
As previously discussed, Commerce’s decisions to use the
18
All the parties agree that salicylic acid is sold in
different grades. See Petition from Law Firm of Stewart &
Stewart to Sec. Of Commerce, P.R. Doc. No. 1 at 13 (May 28,
1999). “[W]ithout further processing, salicylic acid contains
impurities such as sodium sulfate.” Id. This grade is
“typically termed ‘technical’ grade salicylic acid.” Id. at 14.
According to Rhodia, “pharmaceutical grade” salicylic acid,
without any impurities, is needed to produce aspirin. See id.
Although “technical-grade” salicylic acid could be used to
produce USP quality aspirin if it undergoes a “sublimation
process,” see id., there is no indication that the technical-
grade salicylic acid purchased by Shandong actually goes through
such a process. Therefore, Commerce’s determination that
Shandong produces two distinct products is consistent with
Rhodia’s claim that only pharmaceutical grade salicylic acid can
be used to produce USP quality aspirin.
Consol. Court No. 00-08-00407 Page 31
import value of phenol and to exclude the cost of purchased
salicylic acid are supported by substantial evidence and otherwise
in accordance with law. Furthermore, Commerce determined that
“Shandong uses one production process and one production facility
to produce two distinct products.” Decision Memorandum at 20.
Because there is only one production process, Commerce reasonably
concluded that it did not allow Shandong to assign the low-cost
production process to serve as a basis for normal value. Id. at
21.
V. Traded Goods
Commerce, in its final determination, included the cost of
Gujarat’s “trade sales” in the denominator of the factory overhead
rate. “Trade sales” or “traded goods” are products that “are
already manufactured and do not affect production.”19 Timken Co.
v. United States, 23 CIT __, __, 59 F. Supp. 2d 1371, 1379 (1999);
Timken Co., slip op. 01-96, at 48. The Timken cases held that
Commerce should not include sales of traded goods in the
denominator for calculating an overhead ratio because these goods
have no effect on production. Timken Co., slip op. 01-96, at 48-
50.
Commerce, recognizing its error in this regard, asks for a
19
The parties refer to “trade sales” and “traded goods.” In
this case, the reporting of the “trade sales” is synonymous with
“traded goods.” Both are finished merchandise that do not affect
production.
Consol. Court No. 00-08-00407 Page 32
voluntary remand to remove traded goods from the denominator for
the calculation of overhead ratio. Although all the parties agree
that the inclusion of trade sales has a minimal effect on the
overall ratio if Commerce continues to use a weighted average,
remand of this issue to Commerce is appropriate as this court is
remanding other aspects of the final determination, including
Commerce’s use of a weighted average. Accordingly, Commerce’s
request is granted.
Consol. Court No. 00-08-00407 Page 33
Conclusion
The Department shall reconsider its determination in a manner
consistent with this opinion. The Department shall file its remand
determination with the Court within 90 days. The parties are
granted 30 days to file comments on the remand determination. The
Department may respond to any comments filed within 20 days.
______________________
Donald C. Pogue
Judge
Dated: November 30, 2001
New York, New York